VKTX - Kapitalisasi marang volume dodolan Viking Therapeutics Inc

Logo korporat perusahaan Viking Therapeutics Inc (VKTX)

Viking Therapeutics relies on external manufacturing capacities, minimizing risks through long-term contracts. The current P/S ratio clearly confirms market expectations, with the value stabilizing at . The asset's price action depends on FDA approval of the VK2735 drug, while Brian Lian's strategic course ensures prudent capital management and high clinical trial velocity.

VKTX: Multiplikator P/S Viking Pharma 04.07.2022 - 16.11.2026

Rincian analitis perusahaan Viking Therapeutics Corp (VKTX)

- rega saham lan konsensus proyeksi valuasi:
Analisis fundamental perusahaan:Viking Therapeutics, Inc. - VKTX
Produk dadi Viking Pharma

The P/S ratio relates market capitalization to sales volume, allowing for an assessment of business value relative to generated revenue and the identification of asset overheating. The price-to-sales multiple analysis for Viking Therapeutics (VKTX) reflects market expectations regarding the company's future pricing power in the obesity drug segment, where successful clinical trials could justify current premium valuations.

Perusahaan pesaing

BIIB (Biogen) - Rasio kapitalisasi pasar marang pendapatan|Multiplikator P/S NBIX (Neurocrine Corp)|Regencell Bioscience - Rasio rega marang pendapatan|Axsome Therapeutics - Multiplikator P/S|Rasio kapitalisasi pasar marang pendapatan ACAD (ACADIA Pharmaceuticals)|Xenon (XENE) - Rasio rega marang pendapatan|Rasio rega marang dodolan SUPN (Supernus)|CPRX (Catalyst Pharmaceuticals Inc) - Multiplikator P/S|DNLI: Rasio kapitalisasi pasar marang pendapatan|Rasio rega marang pendapatan harmonybiosciences.com (HRMY)|Biohaven - Rasio kapitalisasi marang pendapatan|Multiplikator P/S AMLX (amylyx.com)|Trevi Pharma (TRVI) - Rega marang dodolan|Praxis Corp - Multiplikator P/S|Anavex Corp (AVXL) - Kapitalisasi marang pendapatan|CBLL: Multiplikator P/S|Prothena Biosciences - Rasio kapitalisasi pasar marang pendapatan|ALEC (alector.com) - Multiplikator P/S|Rasio kapitalisasi marang pendapatan ANNX (Annexon Biosciences)|Rasio rega marang pendapatan Omeros Corporation (OMER)|Neurogene Corp - Rasio kapitalisasi marang pendapatan|Rasio rega marang pendapatan AC Immune S.A. ACIU|Koefisien rega marang pendapatan Voyager Therapeutics (VYGR)|Neumora - Multiplikator P/S|Rasio rega marang dodolan SCLX|Tevogen Bio Inc. (TVGN) - Rasio rega marang pendapatan|Rasio kapitalisasi marang pendapatan ACOG|CGTX (cogrx.com) - Multiplikator P/S|Kapitalisasi marang pendapatan inhibikase.com (IKT)|Rasio rega marang pendapatan Cassava Sciences Inc (SAVA)|Koefisien rega marang pendapatan Assertio|Multiplikator P/S COYA (Coya Therapeutics, Inc.)|Kapitalisasi marang volume dodolan VTGN (VistaGen Therapeutics Inc)|OVID: Kapitalisasi marang pendapatan|ABOS: Rasio rega marang pendapatan|CervoMed (CRVO) - Rasio rega marang pendapatan|Rega marang dodolan Alterity Therapeutics Ltd (ATHE)|CLNN (Clene) - Multiplikator P/S|Rasio kapitalisasi marang pendapatan PEPG (PepGen)|Kapitalisasi marang pendapatan JUNS (Jupiter Neurosciences, Inc.)|Multiplikator P/S relmada.com (RLMD)|Rasio rega marang pendapatan Annovis Bio Corp ANVS|GRCE: Rasio kapitalisasi marang pendapatan|AIFF - Rasio rega marang pendapatan|KLTO (anewmeds.com) - Rasio kapitalisasi marang pendapatan|NRSN (NeuroSense Therapeutics Ltd.) - Kapitalisasi marang pendapatan|revivapharma.com - Rasio kapitalisasi pasar marang pendapatan|MTVA (metaviatx.com) - Multiplikator P/S|NRXS: Rasio kapitalisasi pasar marang pendapatan|Multiplikator P/S HSDT|PASG - Rega marang dodolan|Multiplikator P/S NEUP (Neuphoria Therapeutics)|NERV: Rasio kapitalisasi marang pendapatan|ATHA: Kapitalisasi marang pendapatan|Addex Therapeutics Ltd - Kapitalisasi marang volume dodolan|Alzamend Neuro, Inc. (ALZN) - Rasio rega marang pendapatan|CYCN (Cyclerion Therapeutics Inc.) - Rasio rega marang pendapatan|Kapitalisasi marang pendapatan PTIX|KTTA: Rasio kapitalisasi pasar marang pendapatan|Kapitalisasi marang pendapatan CRGT (Cortigent Medical)|ATXI (Avenue Therapeutics, Inc.) - Rasio kapitalisasi pasar marang pendapatan|Rasio rega marang pendapatan Brainstorm Cell Therapeutics, Inc. BCLI|Rasio kapitalisasi pasar marang pendapatan CARA|chromocell.com - Multiplikator P/S|Rasio rega marang dodolan ELYM|ITCI: Multiplikator P/S|Rega marang dodolan Longboard Pharmaceuticals, Inc. (LBPH)|Rasio rega marang pendapatan Marinus Pharmaceuticals, Inc.|NKGN: Rasio kapitalisasi pasar marang pendapatan|Multiplikator P/S NRBO|SAGE: Rasio rega marang dodolan|Synaptogenix Inc. - Kapitalisasi marang pendapatan|Kapitalisasi marang volume dodolan TRVN (Trevena Inc.)|Vigil Neuroscience, Inc. - Multiplikator P/S|Anew Medical (WENA) - Kapitalisasi marang pendapatan|CERE (Cerevel Corp) - Kapitalisasi marang pendapatan